Natera Colorectal Cancer Screening Test Evaluation (FIND-CRC)
This study is looking at how well the Natera Colorectal Cancer Screening Test works in people who have an average risk of getting colorectal cancer (cancer of the large intestine). Researchers will collect blood samples and health information from about 25,000 participants. You can join if you are 40 years or older, plan to have a colonoscopy (a procedure to look inside your colon), and are able to give blood samples. The main goal is to see how accurate the Natera test is after 24 months. The study is currently unclear about its recruitment status.
- Study design
- This is an observational study, meaning researchers will collect information without giving any specific treatments. It plans to enroll about 25,000 participants.
- What's involved
- You would provide blood samples and have a colonoscopy within 120 days of your blood draw. You will not receive any test results from the blood collection.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcome of the study will be measured at 24 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Primary Outcome24 months
The primary outcomes of this study are sensitivity of the Natera CRC Screening Test for the detection of colorectal cancer (CRC) and specificity of the test for advanced neoplasia (AN), as assessed by agreement of the Natera CRC Screening test with colonoscopy findings.